Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.32%) to 9865.97, DAX (0.02%) to 24283.97, CAC40 (0.37%) to 8121.07, STOXX 600 (0.13%) to 586.75

Dec 22 ,2025

  • Synopsis:

    • European indices ended in negative territory, except for Norway and Sweden. On the macro-front, trade tensions between EU and China have ratcheted higher after Beijing levies duties on some dairy imports from the bloc by up to 42.7%. China Commerce Ministry said provisional duties follow first phase of anti-subsidy probe, which will impact products such as some fresh and processed cheeses and cream. Most companies will be affected with tariffs of just under 30% and will take effect from 23-Dec. China launched the investigation in August 2024, shortly after the EU announced its own investigation into subsidies which led to new tariffs in Chinese electric vehicles. Beijing has been pushing for negotiations with the bloc to drop tariffs in exchange for pledge to sell at minimum price. Senior EU diplomats have said there are major issues remain between the two sides. One source said Beijing is pushing for a sector-wide deal that is complicating talks rather than agreements for individual firms. Earlier in the afternoon, wires reported that the US Interior Department announced the suspension of five offshore wind projects, adding that the "pause" impacts the Vineyard Wind 1, Revolution Wind, Commercial, Sunrise Wind, and Empire Wind 1 projects; shares in Orsted and Vestas traded lower on the news

    • Survey by Germany's Ifo Institute showed one in four companies in the country expect business to deteriorate in 2026. Of those surveyed, 26% expect conditions to worsen and 59% do not expect any change in conditions in the coming year. Just 14.9% anticipate an improvement. Ifo head of surveys Wohlrabe highlighted that there is effectively no optimism. Fits in with a disappointing end to the year for German macro indicators. While investors remain upbeat on the prospects for Germany, the recent Ifo business climate index, GfK consumer confidence and PMI came in on the weaker side. Of note, manufacturing has ended the year on a weaker footing, reflected in softer PMI and weakening sentiment. The services sector remains in expansion, though rate of activity has moderated. Construction is subdued and retail environment is challenging. Despite the downbeat tone, outlook for 2026 GDP growth is more optimistic given that impact of expansionary fiscal policy tipped to gain traction. Story of the year German economy has been slow pace of reform and rollout of infrastructure spending

    • Amidst a light macro-calendar, focus on final UK Q3 GDP confirming a weak growth backdrop into year-end and Italian PPI. In geopolitics, the latest Ukraine rhetoric on ceasefire progress is positive. Trump's special envoy Witkoff said talks productive in constructive over the weekend with Ukrainian and European negotiators. Kremlin denied that three-way talks with Ukraine and US were on the cards after Zelenskyy mooted a trilateral format on the weekend. Russia has also renewed criticism of European efforts to amend US peace plan to end war

    • On the reporting front, Intrum (INTRUM.SS) revealed an impairment of SEK 3.4B, whilst Theon International (THEON.NA) issued prelim FY25 numbers; also, Duerr (DUE.GR) raised FY25 forecast for its FCF to €100-€200M from €0-€50M. In Denmark, cBrain (CBRAIN.DC) and NNIT (NNIT.DC) cut their outlook. In M&A news, Harbour Energy (HBR.LN) acquired LLOG Exploration Company LLC from LLOG Holdings LLC for $3.2B whilst - in Finland - Mutares SE & Co (MUX.GR) acquired Wärtsilä (WRT1V.FH) Gas Solutions business and Valmet (VALMT.FH) bought Severn Group from Bluewater in a transaction is valued at $480M on a cash and debt-free basis

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers: Basic Resources +0.81%, Insurance +0.41%, Retail +0.33%, Real Estate +0.32%, Financial Svcs +0.30%, Oil & Gas +0.29%, Travel & Leisure +0.20%, Construct & Mtls +0.12%, Telecom +0.08%, Chemicals (0.00%), Ind Goods & Svcs (0.03%), Media (0.09%)

      • Underperformers: Food & Beverage (1.37%), Autos & Parts (0.96%), Utilities (0.89%), Persnl & HHold Goods (0.38%), Health Care (0.24%), Banks (0.17%), Technology (0.13%)

    • Macro:

      • Too Early, Too Alone: France Prepares for Russia as US Withdraws (Politico)

      • France Needs More Than a New Leader. It Needs a New France. (NY Times)

      • European investment banks fail to capitalise on Trump Tariff turmoil (Reuters)

      • Many voters doubt German gov't will hold until 2029 (dw)

      • Deutsche Telekom Backs German Drone Startup Active in Ukraine (BBG)

      • One in Four Companies in Germany Expect Business to Deteriorate in 2026 (IFO)

      • Sweden and Germany slash aid budgets to focus on Ukraine and defence spending (Guardian)

      • France enlists Russian state-owned company to help make nuclear fuel in Germany (Politico)

      • Giorgia Meloni: Neo-fascist or far right? Why Italian PM's tenure raises questions among political experts (Le Monde)

      • Denmark says US envoy appointment reflects Trump's continued interest in Greenland (Reuters)

    • Company news:

      • Notable Gainers

        • +27.8% ALL.LN (Atlantic Lithium £0.10, +0.02) -- submits revised Ewoyaa Mining Lease to Ghana's Parliament

        • +15.4% ABVX.FP (Abivax €115.40, +15.40) -- Eli Lilly courting French Treasury in order to acquire Abivax - La Lettre

        • +9.9% RANA.NO (Rana Gruber NOK76.90, +6.90) -- Champion Iron enters into agreement to acquire Rana Gruber at NOK79 (A$11.8) per share cash

        • +8.1% SYNACT.SS (SynAct Pharma SEK22.05, +1.65) -- SynAct Pharma CEO says 2026 is going to be a busy year - BioStock

        • +7.9% RKH.LN (Rockhopper Exploration £0.76, +0.06) -- final investment decision on the Sea Lion Project, financial close has now occurred

        • +7.2% DUE.GR (Duerr €22.40, +1.50) -- raises FY25 forecast for free cash flow to €100-€200M from €0-€50M prior

        • +6.2% EAH.LN (Eco Animal Health Group £1.04, +0.06) -- EU marketing authorisation for ECOVAXXIN MS

        • +6.1% WINE.LN (Naked Wines £0.73, +0.04) -- launches share buyback via Reverse Accelerated Bookbuild to purchase ordinary shares of 7.5p each up to max of £2M

        • +4.5% HNSA.SS (Hansa Biopharma SEK30.70, +1.32) -- Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation

        • +4.3% SPM.IM (Saipem €2.48, +0.10) -- awarded offshore EPCI contract from QatarEnergy LNG worth $3.1B (~€2.7B)

        • +4.1% IMMNOV.SS (Immunovia SEK0.23, +0.01) -- publication of analytical validation study in Diagnostics

        • +3.6% ENDUR.NO (Endur ASA NOK88.40, +3.10) -- subsidiary - to acquire Kragerø Sjøtjenester in deal worth ~NOK 63M (EV basis)

        • +3.2% DIE.BB (D'Ieteren Group €153.20, +4.80) -- relaunches €100M share buyback programme

        • +3.1% ATS.AV (AT & S Austria Technologie & Systemtechnik €31.45, +0.95) -- new CFO

        • +2.5% TIT.IM (Telecom Italia €0.51, +0.01) -- calls shareholder meeting on 28-Jan to vote on conversion of savings shares into ordinary shares

        • +2.4% DOFG.NO (DOF Group NOK93.35, +2.15) -- updates on project awards in the Atlantic region and contract award in the North America region

        • +2.4% KDEV.SS (Karolinska Development SEK0.46, +0.01) -- portfolio company SVF Vaccines signs non-binding letter of intent with Novakand Pharma AB regarding reverse takeover

        • +2.3% MAIRE.IM (MAIRE €13.09, +0.29) -- obtains conservatory measures immediately enforceable for €1.1B against EuroChem following leave from the London Arbitral Tribunal

        • +1.9% VALMT.FH (Valmet €27.31, +0.51) -- to acquire Severn Group from Bluewater; transaction is valued at $480M on a cash and debt-free basis

        • +1.8% THEON.NA (Theon International €27.90, +0.50) -- reports prelim FY25

        • +1.6% NEX.FP (Nexans €124.40, +1.90) -- enters exclusive negotiations with Motherson for the sale of Autoelectric for an Entreprise Value of €207M

        • +0.8% SIGHT.FP (GenSight Biologics €0.10, -0.00) -- Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ in France

        • +0.6% INTRUM.SS (Intrum SEK38.12, +0.22) -- impairments

      • Notable Decliners

        • -50.5% PANR.LN (Pantheon Resources £0.09, -0.09) -- update on Dubhe-1

        • -28.6% ENW.LN (Enwell Energy £0.15, -0.06) -- updates on damage to gas processing facilities at VAS Field

        • -12.7% ORSTED.DC (Ørsted DKK117.20, -17.00) -- Interior Department announces suspension of five offshore wind projects, citing national security issues

        • -12.5% CBRAIN.DC (cBrain DKK115.00, -16.40) -- cuts FY25 outlook

        • -4.7% RNK.LN (Rank Group £1.00, -0.05) -- Spanish units hit by €7.1M payment fraud

        • -3.8% SNI.NO (Stolt-Nielsen NOK315.50, -12.50) -- Fearnley downgrade

        • -3.3% NNIT.DC (NNIT DKK48.10, -1.65) -- cuts FY25 outlook and suspends FY27 mid-term financial aspirations

        • -2.6% VWS.DC (Vestas Wind Systems DKK169.20, -4.60) -- Interior Department announces suspension of five offshore wind projects, citing national security issues

        • -2.2% STX.LN (Shield Therapeutics £0.11, -0.00) -- FDA approves extension of the indication for ACCRUFeR (ferric maltol) to include adolescents

        • -1.9% GOFORE.FH (Gofore €13.14, -0.26) -- acqires Esentri AG; announces shares issue

        • -1.6% CATE.SS (Catena SEK434.60, -7.00) -- signs LOI to acquire a large ~SEK 9B Nordic property portfolio

        • -1.2% HBR.LN (Harbour Energy £2.04, -0.02) -- to acquire LLOG Exploration Company LLC from LLOG Holdings LLC for $3.2B

        • -0.3% WJG.LN (Watkin Jones £0.29, -0.00) -- development partnership with Latium Enterprises to deliver a 294-unit hotel in the centre of Wimbledon

    • EU companies reporting tomorrow:

      • none

    • Macro-releases scheduled for tomorrow:

      • Spain Q3 final GDP, Nov PPI,

      • Switzerland Dec economic sentiment index,

      • Sweden Nov PPI,

      • Belgium Dec CPI, Nov PPI,

      • Finland Nov unemployment rate

  • Data:

    • Economics:

      • UK Q3 GDP +1.3% y/y vs preliminary +1.3%; +0.1% q/q vs preliminary +0.1%

      • Italy Nov PPI (0.2%) y/y vs consensus (0.6%), prior +0.1%; +1.0% m/m vs consensus +0.5%, prior (0.2%)

      • Spain Oct trade balance (€4.69B) vs consensus (€6.4B), prior (€6.0B)

      • Finland Nov PPI +0.2% vs consensus (0.1%), prior +0.2%

      • Denmark Q3 GDP +4.0% y/y vs preliminary +3.9%; +2.2% q/q vs preliminary +2.3%

      • Norway Nov unemployment rate 4.5% vs consensus 4.5%, prior revised 4.4% from 4.5%

    • Markets:

      • WTI Crude (Feb 26): +$1.15 or +2.03% to $57.67

      • €-$ +0.0035 or +0.30% to 1.1755

      • £-$ +0.0063 or +0.47% to 1.3449

      • €-£ (0.0015) to 0.8740

      • S&P 500 +0.59%

      • Performance year-to-date

        • FTSE 100: +20.71%

        • DAX: +21.97%

        • CAC: +10.03%

        • MIB: +30.44%

        • Stoxx 600: +15.59%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE